Cargando…

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer

Detalles Bibliográficos
Autores principales:	Ingvarsson, S, Huiping, C, Jonasson, JG, Agnarsson, BA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2000
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300814/ http://dx.doi.org/10.1186/bcr115

Ejemplares similares

Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
por: Huiping, C, et al.
Publicado: (1999)

Restored expression of Fhit protein in Fhit-minus breast cancer cells
por: Campiglio, M, et al.
Publicado: (2001)

Fhit loss in familial breast cancer: is loss of DNA repair function linked to alterations at chromosome fragile sites?
por: Huebner, K, et al.
Publicado: (2001)

Low Incidence of Germline and Somatic Alterations in the E-Cadherin Gene in Lobular Breast Carcinoma
por: Schmutzler, R. K., et al.
Publicado: (1999)

Alterations of E-cadherin and β-catenin in gastric cancer
por: Huiping, Chen, et al.
Publicado: (2001)

Analysis of Fhit expression in stages of breast cancer progression
por: Campiglio, M, et al.
Publicado: (2000)

Point Mutation of the E–Cadherin Gene in Invasive Lobular Carcinoma of the Breast
por: Kanai, Yae, et al.
Publicado: (1994)

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements
por: Christgen, Matthias, et al.
Publicado: (2020)

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)

E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
por: Cleton-Jansen, Anne-Marie
Publicado: (2002)

Preventive effect of Curcumin on AD through increasing PS1/E-cadherin/beta-catenin complex mediated by E-cadherin
por: Zhang, Xiong, et al.
Publicado: (2012)

Deletions at the chromosome 3 common eliminated region 1 on 3p21.3 in human breast tumors
por: Petursdottir, ThE, et al.
Publicado: (2005)

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
por: Vos, C. B., et al.
Publicado: (1997)

Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer
por: Alexander, John, et al.
Publicado: (2022)

Evaluation of FHIT gene alterations in ovarian cancer.
por: Buttitta, F., et al.
Publicado: (1998)

FHIT gene and cancer.
Publicado: (1996)

Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes
por: Engstrøm, Monica J, et al.
Publicado: (2015)

Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors
por: Kim, Jin Hwan, et al.
Publicado: (2014)

E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer
por: Teo, Katy, et al.
Publicado: (2018)

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches
por: Cleton-Jansen, A-M, et al.
Publicado: (2000)

αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer
por: de Groot, Jolien S, et al.
Publicado: (2018)

Constitutional alterations of the ATM gene in early-onset sporadic breast cancer
por: Maillet, P, et al.
Publicado: (2000)

Chromosomal instability and cancer predisposition: insights from studies on the breast cancer susceptibility gene BRCA2
por: Venkitaraman, A
Publicado: (2001)

Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
por: Rätze, Max A. K., et al.
Publicado: (2022)

X chromosome inactivation pattern in female patients with breast cancer
por: Kristiansen, M, et al.
Publicado: (2000)

Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis
por: Zhang, Yaping, et al.
Publicado: (2017)

Abnormalities of the FHIT gene in human oral carcinogenesis
por: Tanimoto, K, et al.
Publicado: (2000)

Alternative Splicing of the FHIT Gene in Colorectal Cancers
por: Hibi, Kenji, et al.
Publicado: (1997)

Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings
por: El Sharouni, Mary-Ann, et al.
Publicado: (2017)

Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
por: Rätze, Max A. K., et al.
Publicado: (2022)

Multiple Patterns of FHIT Gene Homozygous Deletion in Egyptian Breast Cancer Patients
por: Ismail, Heba M. S., et al.
Publicado: (2011)

N-cadherin-ERα-Src signal models mediate the synergistic potentiation of activation of PI3K/Akt signal pathway in injured dopaminergic neurons by GDNF and E2
por: Shi, Zixiao, et al.
Publicado: (2012)

FHIT Doubts are Clear Now
por: Wali, Anjilna
Publicado: (2010)

Identification of alcohol preference relevant genes in QTL on mouse chromosome 2
por: Wang, Lishi, et al.
Publicado: (2011)

Identification of hearing loss relevant genes in QTL on mouse chromosome 16
por: Zhao, Fusheng, et al.
Publicado: (2012)

Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions
por: Aziz, Athar, et al.
Publicado: (2013)

Identification and refinement of two regions on chromosomal arm 15q involved in breast cancer progression
por: Rhiem, K, et al.
Publicado: (2001)

Effects of FHIT gene on proliferation and apoptosis of osteosarcoma cells
por: Xu, Zhengfeng, et al.
Publicado: (2019)

HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer
por: Elnatan, J, et al.
Publicado: (1999)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8tj1580c3t9krvj5voj5n6v7pb